๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Chromosome abnormalities in malignant histiocytosis

โœ Scribed by Yasuhiko Kaneko; Masahiro Kikuchi; Akinori Ishihara; Rokuo Abe; Shojiro Takayama; Masaharu Sakurai


Publisher
John Wiley and Sons
Year
1985
Tongue
English
Weight
939 KB
Volume
56
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

โœฆ Synopsis


Chromosome and pathologic studies were performed on two patients (a 12-year-old boy and a 62-yearold woman) with malignant histiocytosis (MH). Both patients had chromosome abnormalities in their neoplastic cells: the boy's karyotype was 45,Xp+,-Y,9p+,18q-, and the woman's 48,XX+16, inv( l),mar(5),6p-,IOp+,l tq+,i(lh),+i( 18s). The boy had typical clinical and pathologic findings of MH, and died without achieving remission by chemotherapy. At the initial stage the woman had the clinical and hematologic findings of MH. Chemotherapy was given, but had no beneficial effects. At the terminal stage the bone marrow (BM) biopsy and aspirate, and the autopsy findings, were consistent with those of non-Hodgkin lymphoma, diffuse large cell type, although some histiocytes or abnormal cells in monocyte-macrophage lineage remained in the BM and the autopsied lymph nodes. This study and a review of data on six other cases have failed to establish any specific chromosome changes in MH.

Cancer 56:144-151, 1985.

ALIGNANT HIsTiocYTosis (MH), also referred to M as histiocytic medullary reticulosis (HMR), is a systemic disease characterized by diffuse neoplastic proliferation of histiocytes and their precursors in various tissues including lymph nodes (LNs), bone marrow (BM), liver, and spleen.'-3 MH is considered to be a heterogeneous group of diseases in regard to the clinical course as well as the response to chem~therapy.~.' Chromosome studies on leukemia and lymphoma have been done extensively, and have provided essential information regarding their biologic nature and classification! Data on chromosomes in MH, however, are Here, we describe the chromosome findings as well as the clinical, hematologic, and pathologic features in two patients with MH. We also summarize the chromosome pattern in MH from our cases and those in the l i t e r a t ~r e . ~-~


๐Ÿ“œ SIMILAR VOLUMES


High incidence of 17p13 chromosomal abno
โœ Rokuo Abe; Yasushi Akaike; Akiko Yokoyama; Yayoi Shikama; Toshiyuki Ishibashi; M ๐Ÿ“‚ Article ๐Ÿ“… 1990 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 743 KB

Cytogenetic analyses of three patients during autopsy who had a pathologic diagnosis of malignant histiocytosis and of one patient who was strongly suspected to have malignant histiocytosis because of her clinical and hematologic findings were done. All three patients studied with bone marrow specim

Characterization of chromosome 1 abnorma
โœ Damian Smedley; Sanjiv Sidhar; Sandra Birdsall; Dorothy Bennett; Meenhard Herlyn ๐Ÿ“‚ Article ๐Ÿ“… 2000 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 239 KB

Chromosome 1 abnormalities are the most commonly detected aberrations in many cancers including malignant melanomas. Specific breakpoints are reported for malignant melanomas throughout the chromosome but especially at 1p36 and at several sites throughout 1p22-q21. In addition, partial deletions and

Chromosome 16 abnormalities associated w
โœ Lynda J. Campbell; Jacqueline Challis; Thomas Fok; Professor O. Margaret Garson ๐Ÿ“‚ Article ๐Ÿ“… 1991 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 433 KB

Twenty-six patients who had cytogenetic analyses performed for myeloid malignancies at St. Vincent's Hospital over a 6-year period were found to have an inversion abnormality of chromosome 16 (25 patients) or t(16;16) (1 patient). Only 16 patients had all the features of M4Eo, while the other 10 pat

A T-cell neoplasia showing clinicopathol
โœ Takahiro Itoyama; Naoki Sadamoriy; Ippei Sasagawa; Hideo Nakamura; Seiji Tokunag ๐Ÿ“‚ Article ๐Ÿ“… 1991 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 930 KB

Malignant histiocytosis (MH) is a distinct disease entity defined clinically and morphologically. However, the neoplastic origin of MH is not well established. The authors report a 26-year-old woman who showed the typical clinicopathologic features of so-called MH. Cytogenetic and molecular genetic

Chromosome abnormalities in erythroleuke
โœ Judith Stamberg ๐Ÿ“‚ Article ๐Ÿ“… 1987 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 432 KB ๐Ÿ‘ 2 views

Erythroleukemia (EL) is a heterogeneous disease in terms of cell type affected, chromosome abnormalities found in the malignant clone, and clinical course. In this article, cases of erythroid EL from the recent medical literature are reviewed using cytogenetic criteria to distinguish such cases from